New updates have been reported about Insilico Medicine.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Insilico Medicine will release its audited financial results for the year ended December 31, 2025, and provide a strategic business update on March 30, 2026, underscoring an upcoming visibility point for investors into the company’s AI-driven drug discovery pipeline and cash position. Management will host two live earnings calls that day in Beijing Time, signaling active engagement with both international and Mainland China stakeholders.
An English-language webcast is set for 9:00 AM Beijing Time on March 30, 2026, which corresponds to 9:00 PM U.S. Eastern Time on March 29, with advance online registration required to receive access details. A Mandarin-language session will follow at 10:30 AM Beijing Time, with dial-in options provided for Mainland China, Hong Kong, Singapore, the U.S., the U.K., and other international participants, and a replay of the English call will be made available on Insilico Medicine’s website for investors and analysts who cannot attend live.